文献速递脑血管病外科神经重症

吸入麻醉药对动脉瘤性蛛网膜下腔出血后脑血管痉挛的预适应效应

Evidence for a conditioning effect of inhalational anesthetics on angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
PubMed 文献 · J Neurosurg · 2019-06-14

该回顾性队列纳入157例动脉瘤性蛛网膜下腔出血患者,比较单纯吸入麻醉与吸入联合静脉麻醉对造影性血管痉挛及迟发性脑缺血的影响。多因素分析显示单纯吸入麻醉与造影性血管痉挛风险降低独立相关(OR 0.35,95%CI 0.14-0.89),但对迟发性脑缺血及出院功能结局无显著影响。

要点

  • 单纯吸入麻醉与造影性血管痉挛风险降低独立相关(OR 0.35,95%CI 0.14-0.89)。
  • 单纯吸入麻醉对迟发性脑缺血发生率及出院功能结局无显著影响。
  • 地氟烷呼气末浓度越高,迟发性脑缺血发生率越低。

核心结论

  • 这是首个人体证据提示吸入麻醉药可能对蛛网膜下腔出血患者的造影性血管痉挛发挥预适应保护效应。

研究设计与样本

  • 主要结局为住院期间造影性血管痉挛和迟发性脑缺血的发生。

主要发现

  • 单纯吸入麻醉组119例(76%),联合麻醉组34例(22%),单纯吸入组吸入药暴露量显著更高(p < 0.05)。
  • 多因素logistic回归显示单纯吸入麻醉(OR 0.35,95%CI 0.14-0.89)、Hunt and Hess分级(OR 1.51,95%CI 1.03-2.22)和糖尿病(OR 0.19,95%CI 0.06-0.55)是造影性血管痉挛的显著预测因素。
  • 单纯吸入麻醉对迟发性脑缺血发生率或出院功能结局无显著影响,但地氟烷呼气末浓度更高与迟发性脑缺血发生率更低相关。

临床怎么用

  • 动脉瘤性蛛网膜下腔出血患者麻醉方式选择时可考虑单纯吸入麻醉以降低造影性血管痉挛风险,但需注意其对迟发性脑缺血和功能结局的获益尚未证实。

局限性

  • 回顾性研究设计,样本量有限(157例),联合麻醉组仅34例。
  • 单纯吸入麻醉对迟发性脑缺血和出院功能结局无显著影响,地氟烷浓度与迟发性脑缺血的关系需进一步验证。
  • 未来需研究优化吸入麻醉方案是否产生明确的血管痉挛保护作用及是否改善患者结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH) is characterized by large-artery vasospasm, distal autoregulatory dysfunction, cortical spreading depression, and microvessel thrombi. Large-artery vasospasm has been identified as an independent predictor of poor outcome in numerous studies. Recently, several animal studies have identified a strong protective role for inhalational anesthetics against secondary brain injury after SAH including DCI-a phenomenon referred to as anesthetic conditioning. The aim of the present study was to assess the potential role of inhalational anesthetics against cerebral vasospasm and DCI in patients suffering from an SAH. METHODS: After IRB approval, data were collected retrospectively for all SAH patients admitted to the authors' hospital between January 1, 2010, and December 31, 2013, who received general anesthesia with either inhalational anesthetics only (sevoflurane or desflurane) or combined inhalational (sevoflurane or desflurane) and intravenous (propofol) anesthetics during aneurysm treatment. The primary outcomes were development of angiographic vasospasm and development of DCI during hospitalization. Univariate and logistic regression analyses were performed to identify independent predictors of these endpoints. RESULTS: The cohort included 157 SAH patients whose mean age was 56 ± 14 (± SD). An inhalational anesthetic-only technique was employed in 119 patients (76%), while a combination of inhalational and intravenous anesthetics was employed in 34 patients (22%). As expected, patients in the inhalational anesthetic-only group were exposed to significantly more inhalational agent than patients in the combination anesthetic group (p < 0.05). Multivariate logistic regression analysis identified inhalational anesthetic-only technique (OR 0.35, 95% CI 0.14-0.89), Hunt and Hess grade (OR 1.51, 95% CI 1.03-2.22), and diabetes (OR 0.19, 95% CI 0.06-0.55) as significant predictors of angiographic vasospasm. In contradistinction, the inhalational anesthetic-only technique had no significant impact on the incidence of DCI or functional outcome at discharge, though greater exposure to desflurane (as measured by end-tidal concentration) was associated with a lower incidence of DCI. CONCLUSIONS: These data represent the first evidence in humans that inhalational anesthetics may exert a conditioning protective effect against angiographic vasospasm in SAH patients. Future studies will be needed to determine whether optimized inhalational anesthetic paradigms produce definitive protection against angiographic vasospasm; whether they protect against other events leading to secondary brain injury after SAH, including microvascular thrombi, autoregulatory dysfunction, blood-brain barrier breakdown, neuroinflammation, and neuronal cell death; and, if so, whether this protection ultimately improves patient outcome.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Athiraman U, Aum D, Vellimana AK, et al. Evidence for a conditioning effect of inhalational anesthetics on angiographic vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2019. PMID: 31200380. doi:10.3171/2019.3.JNS183512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。